104 related articles for article (PubMed ID: 9528855)
1. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome.
Bonvini P; Nguyen P; Trepel J; Neckers LM
Oncogene; 1998 Mar; 16(9):1131-9. PubMed ID: 9528855
[TBL] [Abstract][Full Text] [Related]
2. Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells.
Feiková S; Wolff L; Bies J
Neoplasma; 2000; 47(4):212-8. PubMed ID: 11043824
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitylation and destruction of endogenous c-mycS by the proteasome: are myc boxes dispensable?
Chen L; Smith L; Accavitti-Loper MA; Omura S; Bingham Smith J
Arch Biochem Biophys; 2000 Feb; 374(2):306-12. PubMed ID: 10666312
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
5. Proteasomal degradation of retinoblastoma-related p130 during adipocyte differentiation.
Prince AM; May JS; Burton GR; Lyle RE; McGehee RE
Biochem Biophys Res Commun; 2002 Jan; 290(3):1066-71. PubMed ID: 11798183
[TBL] [Abstract][Full Text] [Related]
6. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress.
Reinheckel T; Ullrich O; Sitte N; Grune T
Arch Biochem Biophys; 2000 May; 377(1):65-8. PubMed ID: 10775442
[TBL] [Abstract][Full Text] [Related]
7. Evidence for involvement of calpain in c-Myc proteolysis in vivo.
Small GW; Chou TY; Dang CV; Orlowski RZ
Arch Biochem Biophys; 2002 Apr; 400(2):151-61. PubMed ID: 12054425
[TBL] [Abstract][Full Text] [Related]
8. The 26S proteasome: ubiquitin-mediated proteolysis in the tunnel.
Kierszenbaum AL
Mol Reprod Dev; 2000 Oct; 57(2):109-10. PubMed ID: 10984410
[TBL] [Abstract][Full Text] [Related]
9. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
Borriello A; Pietra VD; Criscuolo M; Oliva A; Tonini GP; Iolascon A; Zappia V; Ragione FD
Oncogene; 2000 Jan; 19(1):51-60. PubMed ID: 10644979
[TBL] [Abstract][Full Text] [Related]
10. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
11. Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site.
Flood F; Murphy S; Cowburn RF; Lannfelt L; Walker B; Johnston JA
Biochem J; 2005 Jan; 385(Pt 2):545-50. PubMed ID: 15473868
[TBL] [Abstract][Full Text] [Related]
12. Does an inhibition of the ubiquitin/26S proteasome pathway of protein degradation underlie the pathogenesis of non-familial Alzheimer's disease?
Layfield R
Med Hypotheses; 2001 Mar; 56(3):395-9. PubMed ID: 11359369
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic mechanisms underlying mitochondrial degradation in the ocular lens.
Zandy AJ; Bassnett S
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):293-302. PubMed ID: 17197546
[TBL] [Abstract][Full Text] [Related]
14. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc.
Kalra N; Kumar V
FEBS Lett; 2006 Jan; 580(2):431-6. PubMed ID: 16376880
[TBL] [Abstract][Full Text] [Related]
15. Degradation of MYCN oncoprotein by the ubiquitin system.
Ciechanover A; DiGiuseppe JA; Schwartz AL; Brodeur GM
Prog Clin Biol Res; 1991; 366():37-43. PubMed ID: 1648744
[TBL] [Abstract][Full Text] [Related]
16. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
17. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway.
Gross-Mesilaty S; Reinstein E; Bercovich B; Tobias KE; Schwartz AL; Kahana C; Ciechanover A
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8058-63. PubMed ID: 9653139
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
Tani E; Kitagawa H; Ikemoto H; Matsumoto T
FEBS Lett; 2001 Aug; 504(1-2):53-8. PubMed ID: 11522296
[TBL] [Abstract][Full Text] [Related]
19. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
Gregory MA; Hann SR
Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
[TBL] [Abstract][Full Text] [Related]
20. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells.
Nahreini P; Andreatta C; Prasad KN
Cell Mol Neurobiol; 2001 Oct; 21(5):509-21. PubMed ID: 11860188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
